# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-043439
Filing Date
2022-04-07
Accepted
2022-04-07 08:09:44
Documents
3
Period of Report
2022-05-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2210624-1_def14a.htm | DEF 14A | 525760
2 | GRAPHIC | tm2210624d1-px_01proxybw.jpg | GRAPHIC | 360254
3 | GRAPHIC | tm2210624d1-px_02proxy4c.jpg | GRAPHIC | 219849
| Complete submission text file | 0001104659-22-043439.txt |  | 1306454

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 22812348
SIC: 2834 Pharmaceutical Preparations